Your browser doesn't support javascript.
loading
Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer.
Minor, David R; Moores, Samantha P; Chan, John K.
Afiliação
  • Minor DR; California Pacific Medical Center Research Institute, 2200 Webster St. Suite 511, San Francisco, CA 94115, United States.
  • Moores SP; California Pacific Medical Center Research Institute, 2200 Webster St., San Francisco, CA 94115, United States.
  • Chan JK; California Pacific Medical Center Research Institute/Palo Alto Medical Foundation, 3838 California St., San Francisco, CA 94118, United States.
Gynecol Oncol Rep ; 22: 43-44, 2017 Nov.
Article em En | MEDLINE | ID: mdl-29034306
ABSTRACT
•A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented.•Intraperitoneal IL-2 was given with little toxicity.•Immunotherapy may have the potential for durable remissions in ovarian cancer.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article